Feil Family Brain & Mind Research Institute

Publications

Found 386 results
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
O
Victor JD, Aguilar G, Waraich SA.  2023.  Ordinal Characterization of Similarity Judgments.. ArXiv.
Ashirova E, Contoreggi NH, Johnson MA, Al-Khayat FJ, Calcano GA, Rubin BR, O'Cinneide EM, Zhang Y, Zhou Y, Gregoire L et al..  2020.  Oxycodone injections not paired with conditioned place preference have little effect on the hippocampal opioid system in female and male rats.. Synapse. :e22182.
Ashirova E, Contoreggi NH, Johnson MA, Al-Khayat FJ, Calcano GA, Rubin BR, O'Cinneide EM, Zhang Y, Zhou Y, Gregoire L et al..  2020.  Oxycodone injections not paired with conditioned place preference have little effect on the hippocampal opioid system in female and male rats.. Synapse. :e22182.
P
Sansone P, Savini C, Kurelac I, Chang Q, Amato LBenedetta, Strillacci A, Stepanova A, Iommarini L, Mastroleo C, Daly L et al..  2017.  Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.. Proc Natl Acad Sci U S A. 114(43):E9066-E9075.
Palomo GM, Granatiero V, Kawamata H, Konrad C, Kim M, Arreguin AJ, Zhao D, Milner TA, Manfredi G.  2018.  Parkin is a disease modifier in the mutant SOD1 mouse model of ALS.. EMBO Mol Med.
Sohn PDongmin, Huang CTzu-Ling, Yan R, Fan L, Tracy TE, Camargo CM, Montgomery KM, Arhar T, Mok S-A, Freilich R et al..  2019.  Pathogenic Tau Impairs Axon Initial Segment Plasticity and Excitability Homeostasis.. Neuron. 104(3):458-470.e5.
Sohn PDongmin, Huang CTzu-Ling, Yan R, Fan L, Tracy TE, Camargo CM, Montgomery KM, Arhar T, Mok S-A, Freilich R et al..  2019.  Pathogenic Tau Impairs Axon Initial Segment Plasticity and Excitability Homeostasis.. Neuron. 104(3):458-470.e5.
Murthy SB, Awad I, Harnof S, Aldrich F, Harrigan M, Jallo J, Caron J-L, Huang J, Camarata P, Lara LRivera et al..  2017.  Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.. Neurology. 89(4):355-362.
Murthy SB, Awad I, Harnof S, Aldrich F, Harrigan M, Jallo J, Caron J-L, Huang J, Camarata P, Lara LRivera et al..  2017.  Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.. Neurology. 89(4):355-362.
Butelman ER, Huang Y, Shastry S, Manini AF, Goldstein RZ, Alia-Klein N.  2025.  Polydrug overdose mortality caused by synthetic opioids and stimulants: current sex- and age-specific trajectories in United States national data for 2018-2024.. Neuropsychopharmacology.
Gelderblom M, Koch S, Strecker J-K, Jørgensen C, Garcia-Bonilla L, Ludewig P, Schädlich ISophie, Piepke M, Degenhardt K, Bernreuther C et al..  2023.  A preclinical randomized controlled multi-centre trial of anti-interleukin-17A treatment for acute ischaemic stroke.. Brain Commun. 5(2):fcad090.
Gelderblom M, Koch S, Strecker J-K, Jørgensen C, Garcia-Bonilla L, Ludewig P, Schädlich ISophie, Piepke M, Degenhardt K, Bernreuther C et al..  2023.  A preclinical randomized controlled multi-centre trial of anti-interleukin-17A treatment for acute ischaemic stroke.. Brain Commun. 5(2):fcad090.
Ferenczi EA, Zalocusky KA, Liston C, Grosenick L, Warden MR, Amatya D, Katovich K, Mehta H, Patenaude B, Ramakrishnan C et al..  2016.  Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior.. Science. 351(6268):aac9698.
Hachinski V, Einhäupl K, Ganten D, Alladi S, Brayne C, Stephan BCM, Sweeney MD, Zlokovic B, Iturria-Medina Y, Iadecola C et al..  2019.  Preventing dementia by preventing stroke: The Berlin Manifesto.. Alzheimers Dement. 15(7):961-984.
Joyce RL, Tibbs GR, J Warren D, Costa CJ, Aromolaran K, R Sanford L, Andersen OS, Li Z, Zhang G, Willis DE et al..  2023.  Probucol is anti-hyperalgesic in a mouse peripheral nerve injury model of neuropathic pain.. Neurobiol Pain. 14:100141.
Joyce RL, Tibbs GR, J Warren D, Costa CJ, Aromolaran K, R Sanford L, Andersen OS, Li Z, Zhang G, Willis DE et al..  2023.  Probucol is anti-hyperalgesic in a mouse peripheral nerve injury model of neuropathic pain.. Neurobiol Pain. 14:100141.
Claassen J, Akbari Y, Alexander S, Bader MKay, Bell K, Bleck TP, Boly M, Brown J, Chou SH-Y, Diringer MN et al..  2021.  Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.. Neurocrit Care. 35(Suppl 1):4-23.
Claassen J, Akbari Y, Alexander S, Bader MKay, Bell K, Bleck TP, Boly M, Brown J, Chou SH-Y, Diringer MN et al..  2021.  Proceedings of the First Curing Coma Campaign NIH Symposium: Challenging the Future of Research for Coma and Disorders of Consciousness.. Neurocrit Care. 35(Suppl 1):4-23.
Wong JK, Deuschl G, Wolke R, Bergman H, Muthuraman M, Groppa S, Sheth SA, Bronte-Stewart HM, Wilkins KB, Petrucci MN et al..  2022.  Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury.. Front Hum Neurosci. 16:813387.
Wong JK, Deuschl G, Wolke R, Bergman H, Muthuraman M, Groppa S, Sheth SA, Bronte-Stewart HM, Wilkins KB, Petrucci MN et al..  2022.  Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury.. Front Hum Neurosci. 16:813387.
Milicevic KD, Abreu AC, Chandran G, Zhu YMD, Hu X, Ivanova VO, Jami M, Simon B, Fernández I, Yan R et al..  2026.  Prodromal changes in cortical neuron physiology before amyloid pathology in a mild model of Alzheimer's disease.. Sci Rep.
Milicevic KD, Abreu AC, Chandran G, Zhu YMD, Hu X, Ivanova VO, Jami M, Simon B, Fernández I, Yan R et al..  2026.  Prodromal changes in cortical neuron physiology before amyloid pathology in a mild model of Alzheimer's disease.. Sci Rep.
Anderson CJ, Kahl A, Qian L, Stepanova A, Starkov A, Manfredi G, Iadecola C, Zhou P.  2018.  Prohibitin is a positive modulator of mitochondrial function in PC12 cells under oxidative stress.. J Neurochem.
Anderson CJ, Kahl A, Fruitman H, Qian L, Zhou P, Manfredi G, Iadecola C.  2019.  Prohibitin levels regulate OMA1 activity and turnover in neurons.. Cell Death Differ.
Qu Y, Konrad C, Anderson C, Qian L, Yin T, Manfredi G, Iadecola C, Zhou P.  2020.  Prohibitin S-Nitrosylation Is Required for the Neuroprotective Effect of Nitric Oxide in Neuronal Cultures.. J Neurosci. 40(16):3142-3151.